Provid Pharmaceuticals Inc. is a drug discovery service company that provides expert medicinal chemistry support to the biotech and pharmaceutical industries. These services aid a variety of research organizations ranging from start-ups to large pharma, as well as government labs and academic groups. Provid applies world-class medicinal chemistry and drug development experience to transform the biological discoveries made by our customers into commercial opportunities.

• We are committed to close communication with our clients to understand their needs, to establish project objectives, and to adapt and evolve R&D plans in response to experimental results.
• We understand that drug discovery is an art as well as a science. We therefore pursue hypothesis-driven strategies while utilizing our creative insights in drug development to drive projects to a meaningful conclusion.
• Our scientists work to solve challenging problems culminating in the invention of new drug molecules and, most importantly, the creation of novel intellectual property for our customers.

At Provid, our researchers possess core competencies in all aspects of medicinal chemistry, organic synthesis, structure-based drug design, peptide mimetics, hit-to-lead translation, and lead optimization. Our scientific team’s repertoire encompasses multiple medicinal chemistry and therapeutic areas, as well as a wide range of drug target classes. We harness these capabilities to both complement and supplement ongoing scientific efforts by our clients, or to pursue a new approach.

Core competencies and capabilities

• All aspects of medicinal and synthetic chemistry
• Rational and structure-based drug design; molecular modeling
• Small molecule chemistry of all types
• Prodrugs, drug targeting and transport
• Peptides and peptide mimetics
• Target classes: receptors, enzymes, protein interactions, aggregation

In addition to our classical medicinal chemistry services, Provid uniquely offers Experimental Due Diligence (EXPEDD™). This service is an intellectual and experimental exploration designed to evaluate and validate opportunities being considered for investment, in-licensing, or portfolio rationalization. EXPEDD can benefit companies, business development and corporate licensing teams, technology transfer departments, and venture capital firms and their portfolio companies by probing questions dealing with the potential of a proposed opportunity to be transformed from an early, interesting scientific result into a valuable drug molecule.

Download PDF's describing:

Provid Drug Discovery Services Brochure (PDF)
Experimental Due Diligence EXPEDD (PDF)
Peptide Mimetics Technology Peptide Mimetics (PDF)